9.89% to Target, JP Morgan Cazenove Keeps Overweight Rating for RELX Plc (LON:REL) Stock; Sprint (S) Sentiment Is 1.06

December 7, 2017 - By Michael Collier

Sprint Corporation, through its subsidiaries, provides various wireless and wireline communications services and products to consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. The company has market cap of $22.76 billion. Virgin Islands. It currently has negative earnings. The firm operates in two divisions, Wireless and Wireline.

The company have set target price of GBX 1905.00 on RELX Plc (LON:REL) shares. This is 9.89% from the close price. In a research report revealed to clients and investors on Thursday, 7 December, JP Morgan Cazenove reiterated their Overweight rating on shares of REL.

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $201,105 activity.

Analysts await Sprint Corporation (NYSE:S) to report earnings on January, 30. They expect $-0.04 EPS, up 66.67% or $0.08 from last year’s $-0.12 per share. After $-0.01 actual EPS reported by Sprint Corporation for the previous quarter, Wall Street now forecasts 300.00% negative EPS growth.

The stock decreased 0.87% or $0.05 during the last trading session, reaching $5.69. About 13.79M shares traded. Sprint Corporation (S) has risen 120.49% since December 7, 2016 and is uptrending. It has outperformed by 103.79% the S&P500.

Mig Capital Llc holds 9.18% of its portfolio in Sprint Corporation for 7.35 million shares. Odey Asset Management Group Ltd owns 8.12 million shares or 7.35% of their US portfolio. Moreover, Discovery Capital Management Llc Ct has 5.31% invested in the company for 26.63 million shares. The Ontario – Canada-based Ontario Teachers Pension Plan Board has invested 4.68% in the stock. Hoertkorn Richard Charles, a California-based fund reported 690,140 shares.

Among 19 analysts covering Reed Elsevier PLC (LON:REL), 13 have Buy rating, 1 Sell and 5 Hold. Therefore 68% are positive. Reed Elsevier PLC has GBX 1990 highest and GBX 20 lowest target. GBX 1646.83’s average target is -5.19% below currents GBX 1737 stock price. Reed Elsevier PLC had 138 analyst reports since July 23, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Barclays Capital on Friday, July 28. The rating was maintained by Investec on Wednesday, January 13 with “Buy”. Investec maintained RELX PLC (LON:REL) on Thursday, February 25 with “Buy” rating. The stock of RELX PLC (LON:REL) earned “Hold” rating by Deutsche Bank on Thursday, February 16. BNP Paribas maintained the stock with “Outperform” rating in Friday, October 28 report. On Friday, January 13 the stock rating was maintained by Goldman Sachs with “Neutral”. The stock of RELX PLC (LON:REL) has “Buy” rating given on Tuesday, February 28 by Berenberg. Societe Generale maintained RELX PLC (LON:REL) rating on Friday, February 24. Societe Generale has “Buy” rating and GBX 1760 target. The firm has “Overweight” rating by Barclays Capital given on Monday, November 23. The firm earned “Hold” rating on Monday, February 27 by Numis Securities.

The stock increased 0.52% or GBX 9 during the last trading session, reaching GBX 1737. About 785,793 shares traded. RELX PLC (LON:REL) has 0.00% since December 7, 2016 and is . It has underperformed by 16.70% the S&P500.

RELX PLC provides information and analytics for professional and business clients in North America, Europe, and internationally. The company has market cap of 34.73 billion GBP. The companyÂ’s Scientific, Technical & Medical segment offers information, analytics, and tools that help clients make decisions. It has a 27.62 P/E ratio. This segment provides research, reference, and education content; and database and decision tools for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive firms, and governments.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com